SIRTURO 100 mg/1
Bedaquiline Fumarate · TABLET · Janssen Products, LP
Sirturo is a prescription tablet containing bedaquiline that is used to treat certain types of tuberculosis infections. It works by targeting the bacteria that cause tuberculosis and is typically used as part of a combination treatment regimen.
Key Facts
- Brand Name
- SIRTURO
- Generic Name
- Bedaquiline Fumarate
- NDC Code (Product)
59676-701- Manufacturer
- Janssen Products, LP
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA204384
- Marketing Start
- 12/28/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is SIRTURO used for?
Sirturo is a prescription tablet containing bedaquiline that is used to treat certain types of tuberculosis infections. It works by targeting the bacteria that cause tuberculosis and is typically used as part of a combination treatment regimen.
Is SIRTURO a controlled substance?
SIRTURO is not classified as a controlled substance by the DEA.
What is the generic name for SIRTURO?
The generic name for SIRTURO is Bedaquiline Fumarate. There are no other listed brand versions of Bedaquiline Fumarate.
What is the NDC code for SIRTURO 100 mg/1?
The NDC (National Drug Code) for SIRTURO 100 mg/1 is 59676-701, listed by Janssen Products, LP.
Other SIRTURO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)